Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale

Catheterization and Cardiovascular Interventions

Volumn 63, Issue 4, 2004, Pages 490-495

  Schwerzmann, Markus ^a   Windecker, Stephan ^a   Wahl, Andreas ^a   Nedeltchev, Krassen ^b   Mattle, Heinrich P ^b   Seiler, Christian ^a   Meier, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b Neurologische Universitatsklinik Bern   (Switzerland)

Author keywords

Cryptogenic stroke; Patent foramen ovale; Percutaneous intervention

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; EMBOLISM; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; IMPLANTATION; MALE; RISK FACTOR; SAFETY; SECONDARY PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; REOPERATION; SWITZERLAND; TREATMENT OUTCOME;

EID: 9644276997     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20221     Document Type: Article

References (15)

1. Bogousslavsky J, Devuyst G, Nendaz M, Yamamoto H, Sarasin F. Prevention of stroke recurrence with presumed paradoxical embolism. J Neurol 1997;244:71-75.
2. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
3. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-1908.
4. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
5. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 2002;105:2845-2848.
6. Amiri M, Schmidley JW, Fink LM, Nazarian SM. Is testing for inherited coagulation inhibitor deficiencies in young stroke patients worthwhile? Clin Neurol Neurosurg 2000;102:219-222.
7. Blohorn A, Guegan-Massardier E, Triquenot A, Onnient Y, Tron F, Borg JY, et al. Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients. Cerebrovasc Dis 2002;13:156-162.
8. Meier B. Pacman sign during device closure of the patent foramen ovale. Catheter Cardiovasc Interv 2003;60:221-223.
9. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-462.
10. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-390.
11. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
12. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
13. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003;107:5-9.
14. Wahl A, Meier B, Haxel B, Nedeltchev K, Arnold M, Eicher E, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001;57:1330-1332.
15. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758.